Skip to main content
An official website of the United States government
Español
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

cabozantinib-s-malate

(KA-boh-ZAN-tih-nib ... MA-layt)
A drug used alone or with other drugs under the brand name Cabometyx to treat certain types of differentiated thyroid cancer, hepatocellular carcinoma (a type of liver cancer), neuroendocrine tumors, and renal cell carcinoma (a type of kidney cancer). It is used under the brand name Cometriq to treat certain types of medullary thyroid cancer. Cabozantinib-s-malate is also being studied in the treatment of other types of cancer. It blocks certain proteins, which may help keep cancer cells from growing. It may also prevent the growth of new blood vessels that tumors need to grow. Cabozantinib-s-malate is a type of tyrosine kinase inhibitor and a type of angiogenesis inhibitor.
More Information
Search NCI's Dictionary of Cancer Terms